Organiser profile image

EyeTherapy, Department of Genetics, UCL Institute of Ophthalmology

https://www.ucl.ac.uk/ioo/genetics/gene-and-cell-therapy

EyeTherapy is the patient and public involvement and engagement team for the Gene and Cell Therapy Group, Department of Genetics, UCL Institute of Ophthalmology. 

Our aim is to increase public awareness and understanding of gene and cell therapy research among people with severe vision loss, their families, friends, carers and the broader public. 

The Gene and Cell Therapy Group are conducting vision impairment research into:

  • Gene therapies for retinal dystrophies and corneal disease
  • Cell therapy
  • Uveitis and neovascularisation

In 2009 the group commenced the world's first gene therapy trial in the eye, testing the safety and efficacy of delivering the RPE65 gene to the eyes of patients with Leber Congenital Amaurosis type 2 and in 2012 began Europe's first trial testing the safety of transplanting human embryonic stem cell-derived retinal pigment epithelium cells into the eyes of patients with Stargardt disease; a trial in partnership with Advanced Cell Technology; now Ocata Therapeutics.

For further information you can contact the EyeTherapy team using the 'contact' us link below - Dr Andi Skilton (Patient and Public Involvement & Engagement Senior Research Associate) or Miss Heather Kneale (Executive Assistant to Professor Robin Ali, Head of the Department of Genetics).

Sorry, there are no upcoming events